The Next Shopify (TSX:SHOP): 2 Stocks That Could Rise by 1,000%

Two potential superstars in the technology sector could rise by up to 1,000%.

| More on:
top tsx stocks

top tsx stocks

The TMX Group launched the TSX30 in 2019, where Shopify made it in all three lists. It ranked number one in 2020 and second in 2019 and 2021. Also, Canada’s largest publicly-listed company rules the technology sector.

Several names are potential superstars, but either CGI Inc. (TSX:GIB.A)(NYSE:GIB) or Nuvei Corp. (TSX:NVEI)(NASDAQ:NVEI) are most likely to be the next tech phenomenon on the TSX. The respective businesses have long growth runways, and it should be a matter time before both are in the league of Shopify and other high-growth stocks. The share prices could even rise by $1,000.

Driving digital transformation

CGI has a market cap of $26.66 billion and is one of the largest independent IT and business consulting services firms globally. The Montreal-based company delivers an end-to-end portfolio of capabilities such as strategic IT & business consulting plus systems integration and managed IT & business process services.

Management’s primary goal is to assist organizations in their digital transformation journeys and accelerate results. More importantly, CGI provides the expertise and insight to drive innovation without disruption. CGI’s different products and services apply to nearly all commercial sectors.

In fiscal 2021 (year ended September 30, 2021), net earnings grew 22.5% to $1.37 billion versus fiscal 2020. CGI generated $526.9 million in cash from operating activities in Q4 fiscal 2021, a 7.1% year-over-increase. Also, note that the company has a backlog worth $23.06 billion.

Its President and CEO, George Schindler, highlights CGI’s strong position and accelerating growth in fiscal 2021. Schindler said, “Looking to the year ahead, we will accelerate our investments in the talent and capabilities necessary to expand our services and global footprint in support of clients’ evolving digital transformations.”

This tech stock trades at $108.78 per share (+7.71% year-to-date gain). Based on analysts’ forecasts, the return potential of 17.3% in 12 months. Note that the total return in 33.3 years is 107,005.93 (23.31% CAGR).

Tech solutions to remove payment barriers

Nuvei should benefit significantly from the ongoing transformation in the digital payments space. The $10.83 billion global payment technology provides intelligence and technology solutions that help businesses remove payment barriers.

If not for automation, payment processing would still be time-consuming today. Nuvei’s proprietary platform offers seamless pay-in and payout capabilities. Moreover, expansion and enhancement of its portfolio of real-time payout options are ongoing.

In the nine months ended September 30, 2021, total revenue and volume increased 97% and 119% year-over-year. Nuvei posted a net income of US$94.7 million compared to US$126.2 million net loss in the same period of 2020. Its Chairman and CEO, Philip Fayer, said the company achieved significant milestones in Q3 2021 besides the financial results exceeding its outlook.

Management expects to end 2021 with total revenue of between US$717 million and US$723 million. It forecasts an identical 30% growth in revenue and volume regarding medium-term targets. The strategy is to accelerate its investment in distribution, marketing, innovation, technology and infrastructure.

Market analysts are bullish on Nuvei, as evidenced by their price forecasts. The current share price of $75.32 could climb 114.9% to $161.88 in 12 months.

Fast-emerging superstars

For years to come, Shopify will be the face of TSX’s tech sector. However, CGI and Nuvei could succeed and be the next superstars.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns and recommends Nuvei Corporation and Shopify. The Motley Fool recommends CGI GROUP INC CL A SV and TMX GROUP INC. / GROUPE TMX INC.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »